Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell line

Autor: Van Der Steen, Nele, Leonetti, Alessandro, Keller, Kaylee, Dekker, Henk, Funel, Niccola, Lardon, Filip, Ruijtenbeek, Rob, Tiseo, Marcello, Rolfo, Christian, Pauwels, Patrick, Peters, Godefridus J., Giovannetti, Elisa
Zdroj: In Biochemical Pharmacology August 2019 166:128-138
Databáze: ScienceDirect